156 related articles for article (PubMed ID: 24939416)
41. CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women.
Yoon KA; Kim JH; Gil HJ; Hwang H; Hwangbo B; Lee JS
Lung Cancer; 2008 Apr; 60(1):40-46. PubMed ID: 17980933
[TBL] [Abstract][Full Text] [Related]
42. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.
Hefler LA; Tempfer CB; Grimm C; Lebrecht A; Ulbrich E; Heinze G; Leodolter S; Schneeberger C; Mueller MW; Muendlein A; Koelbl H
Cancer; 2004 Jul; 101(2):264-9. PubMed ID: 15241822
[TBL] [Abstract][Full Text] [Related]
43. An association selected polymorphisms of XRCC1, OGG1 and MUTYH gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer.
Przybylowska K; Kabzinski J; Sygut A; Dziki L; Dziki A; Majsterek I
Mutat Res; 2013; 745-746():6-15. PubMed ID: 23618615
[TBL] [Abstract][Full Text] [Related]
44. Genetic variations in the xenobiotic-metabolizing enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and susceptibility to colorectal cancer among Turkish people.
Özhan G; Mutur M; Ercan G; Alpertunga B
Genet Test Mol Biomarkers; 2014 Apr; 18(4):223-8. PubMed ID: 24527758
[TBL] [Abstract][Full Text] [Related]
45. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.
Rouissi K; Ouerhani S; Hamrita B; Bougatef K; Marrakchi R; Cherif M; Ben Slama MR; Bouzouita M; Chebil M; Ben Ammar Elgaaied A
Pathol Oncol Res; 2011 Dec; 17(4):879-86. PubMed ID: 21647780
[TBL] [Abstract][Full Text] [Related]
46. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
47. Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis.
Chen J; Sun N; Hu G; Chen X; Jiang J; Wu H; Luo G
Crit Rev Eukaryot Gene Expr; 2017; 27(3):267-275. PubMed ID: 29199611
[TBL] [Abstract][Full Text] [Related]
48. [Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer].
Gao JP; Huang YD; Yang GZ; Yang YQ
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):32-5. PubMed ID: 12680328
[TBL] [Abstract][Full Text] [Related]
49. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
50. An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population.
Kabzinski J; Przybylowska K; Dziki L; Dziki A; Majsterek I
Cancer Biomark; 2015; 15(4):413-23. PubMed ID: 25835182
[TBL] [Abstract][Full Text] [Related]
51. Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk.
Cleary SP; Cotterchio M; Shi E; Gallinger S; Harper P
Am J Epidemiol; 2010 Nov; 172(9):1000-14. PubMed ID: 20937634
[TBL] [Abstract][Full Text] [Related]
52. Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
Koda M; Iwasaki M; Yamano Y; Lu X; Katoh T
Environ Health Prev Med; 2017 Oct; 22(1):72. PubMed ID: 29165164
[TBL] [Abstract][Full Text] [Related]
53. The PTPN13 Y2081D (T>G) (rs989902) polymorphism is associated with an increased risk of sporadic colorectal cancer.
Laczmanska I; Karpinski P; Gil J; Laczmanski L; Makowska I; Bebenek M; Ramsey D; Sasiadek MM
Colorectal Dis; 2017 Jul; 19(7):O272-O278. PubMed ID: 28504867
[TBL] [Abstract][Full Text] [Related]
54. Role of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in Han Chinese: a case-control study.
Shen Y; Xu Q; Ren M; Cai Y; Xu J
J Obstet Gynaecol Res; 2014 Apr; 40(4):1077-84. PubMed ID: 24320736
[TBL] [Abstract][Full Text] [Related]
55. CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Diagn Ther; 2014 Aug; 18(4):445-50. PubMed ID: 24626963
[TBL] [Abstract][Full Text] [Related]
56. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
[TBL] [Abstract][Full Text] [Related]
57. Association between ERCC1 and XPF polymorphisms and risk of colorectal cancer.
Yang H; Li G; Li WF
Genet Mol Res; 2015 Jan; 14(1):700-5. PubMed ID: 25730007
[TBL] [Abstract][Full Text] [Related]
58. Maternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis risk.
Jenkins MM; Reefhuis J; Gallagher ML; Mulle JG; Hoffmann TJ; Koontz DA; Sturchio C; Rasmussen SA; Witte JS; Richter P; Honein MA;
Am J Med Genet A; 2014 Jun; 164A(6):1454-63. PubMed ID: 24668907
[TBL] [Abstract][Full Text] [Related]
59. NAT2 polymorphisms and sporadic colorectal cancer survival.
Osian G; Procopciuc L; Vlad L; Iancu C; Cristea PG; Mocan T; Mocan L
J Gastrointestin Liver Dis; 2010 Dec; 19(4):361-8. PubMed ID: 21188325
[TBL] [Abstract][Full Text] [Related]
60. Association of single nucleotide polymorphisms of ERCC1 and XPF with colorectal cancer risk and interaction with tobacco use.
Hou R; Liu Y; Feng Y; Sun L; Shu Z; Zhao J; Yang S
Gene; 2014 Sep; 548(1):1-5. PubMed ID: 24861646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
